Country Trust Bank’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2
| Closed | -$367 | – | 631 |
|
|
2026
Q1 | $367 | Hold |
2
| – | – | ﹤0.01% | 550 |
|
|
2025
Q4 | $352 | Hold |
2
| – | – | ﹤0.01% | 585 |
|
|
2025
Q3 | $280 | Buy |
+2
| New | +$270 | ﹤0.01% | 608 |
|
|
2021
Q4 | – | Sell |
-74
| Closed | -$21K | – | 503 |
|
|
2021
Q3 | $21K | Sell |
74
-96,932
| -100% | -$31.8M | ﹤0.01% | 271 |
|
|
2021
Q2 | $33.6M | Sell |
97,006
-19,664
| -17% | -$5.96M | 1% | 35 |
|
|
2021
Q1 | $32.6M | Buy |
116,670
+25,605
| +28% | +$6.91M | 1.04% | 31 |
|
|
2020
Q4 | $22.3M | Sell |
91,065
-4,053
| -4% | -$1.05M | 0.77% | 57 |
|
|
2020
Q3 | $27M | Sell |
95,118
-2,657
| -3% | -$741K | 1.03% | 34 |
|
|
2020
Q2 | $26.2M | Buy |
97,775
+2,632
| +3% | +$791K | 1.05% | 35 |
|
|
2020
Q1 | $30.1M | Buy |
95,143
+8,469
| +10% | +$2.57M | 1.35% | 25 |
|
|
2019
Q4 | $25.7M | Sell |
86,674
-16,094
| -16% | -$4.47M | 1.01% | 46 |
|
|
2019
Q3 | $23.9M | Sell |
102,768
-6,335
| -6% | -$1.48M | 1.03% | 46 |
|
|
2019
Q2 | $25.5M | Buy |
109,103
+384
| +0.4% | +$88.7K | 1.11% | 38 |
|
|
2019
Q1 | $25.7M | Sell |
108,719
-3,999
| -4% | -$1.26M | 1.14% | 39 |
|
|
2018
Q4 | $33.9M | Buy |
112,718
+5,586
| +5% | +$1.78M | 1.69% | 15 |
|
|
2018
Q3 | $37.9M | Sell |
107,132
-12,828
| -11% | -$4.42M | 1.75% | 14 |
|
|
2018
Q2 | $34.8M | Buy |
119,960
+21,971
| +22% | +$6.18M | 1.49% | 24 |
|
|
2018
Q1 | $26.8M | Sell |
97,989
-10,599
| -10% | -$3.29M | 1.28% | 29 |
|
|
2017
Q4 | $34.6M | Buy |
108,588
+2,978
| +3% | +$955K | 1.49% | 25 |
|
|
2017
Q3 | $33.1M | Buy |
105,610
+11,934
| +13% | +$3.53M | 1.5% | 24 |
|
|
2017
Q2 | $25.4M | Buy |
93,676
+3,858
| +4% | +$1.02M | 1.21% | 36 |
|
|
2017
Q1 | $24.6M | Buy |
89,818
+2,383
| +3% | +$674K | 1.22% | 36 |
|
|
2016
Q4 | $24.8M | Sell |
87,435
-1,969
| -2% | -$584K | 1.26% | 34 |
|
|
2016
Q3 | $28M | Buy |
89,404
+6,360
| +8% | +$1.88M | 1.45% | 26 |
|
|
2016
Q2 | $20.1M | Buy |
83,044
+6,603
| +9% | +$1.74M | 1.08% | 44 |
|
|
2016
Q1 | $19.9M | Buy |
76,441
+52,753
| +223% | +$13.9M | 1.07% | 43 |
|
|
2015
Q4 | $7.26M | Buy |
23,688
+5,143
| +28% | +$1.48M | 0.4% | 73 |
|
|
2015
Q3 | $5.41M | Buy |
+18,545
| New | +$6.12M | 0.3% | 79 |
|
Other funds holding BIIB
Country Trust Bank's BIIB Position: Q2 2026 in Review
Country Trust Bank sold out of Biogen (BIIB) in Q2 2026, closing a stake of 2 shares — an estimated $367 sold.
Country Trust Bank first reported a position in BIIB in Q3 2015 and held it in 28 quarters. The position peaked at $37.9M in Q3 2018. 746 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Country Trust Bank reported no remaining Biogen position as of Q2 2026 after selling out during the quarter.
- Country Trust Bank sold 2 Biogen shares in Q2 2026, an estimated $367.
- Country Trust Bank first reported a position in Biogen in Q3 2015 and held it in 28 quarters.
- Country Trust Bank's Biogen position peaked at $37.9M in Q3 2018.
- 746 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Country Trust Bank's 13F filing for Q2 2026, filed 15 Jul 2026.